4min chapter

All-In with Chamath, Jason, Sacks & Friedberg cover image

E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more

All-In with Chamath, Jason, Sacks & Friedberg

CHAPTER

Is the FDA Approving a Drug Where There's No Clear Evidence?

The FDA has approved a drug with no clear evidence that it leads to clinical benefits. The move could set a precedent where companies can get drugs approved on limited evidence, says Chamot. But the economic incentive could drive further inervation in the space which ultimately could benefit patients more truly than this current drug.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode